Application | Comment | Organism |
---|---|---|
drug development | ability of monoclonal antibodies F1-2 and F1-40 to provide therapeutic protection against BoNT/A intoxication in mouse intravenous and oral intoxication models, overview | Clostridium botulinum |
Protein Variants | Comment | Organism |
---|---|---|
E224A | the mutation abrogates the catalytic activity of the endopeptidase of BoNT/A | Clostridium botulinum |
H223A | the mutation abrogates the catalytic activity of the endopeptidase of BoNT/A | Clostridium botulinum |
H227A | the mutation abrogates the catalytic activity of the endopeptidase of BoNT/A | Clostridium botulinum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | monoclonal antibodies F1-2 and F1-40 do not inhibit the catalytic activity of BoNT/A, but inhibit the entry of the toxin into host neuronal cells, leading to reduced toxicity to mice, and block intracellular SNAP25 cleavage, overview | Clostridium botulinum |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Zn2+ | required | Clostridium botulinum |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Clostridium botulinum | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
SNAP-25 + H2O | i.e. 25-kDa synaptosome-associated protein | Clostridium botulinum | ? | - |
? | |
SNAPtide + H2O | i.e. SNAPtide, as recombinant human SNAP25bHA protein expressed in Escherichia coli | Clostridium botulinum | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
BoNT serotype A | - |
Clostridium botulinum |
BoNT/A | - |
Clostridium botulinum |
Botulinum neurotoxin | - |
Clostridium botulinum |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Clostridium botulinum |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Clostridium botulinum |